{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:46:35Z","timestamp":1795009595141,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91842103\/31870907\/81930041"],"award-info":[{"award-number":["91842103\/31870907\/81930041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Z19h100001"],"award-info":[{"award-number":["Z19h100001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-023-00973-7","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T02:02:52Z","timestamp":1674612172000},"page":"292-304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes"],"prefix":"10.1038","volume":"20","author":[{"given":"Wenjuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishuo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-018X","authenticated-orcid":false,"given":"Lihua","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0415-0052","authenticated-orcid":false,"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"973_CR1","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ, et al. Psoriasis. Nat Rev Dis Prim. 2016;2:16082.","journal-title":"Nat Rev Dis Prim"},{"key":"973_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","volume":"68","author":"J Kim","year":"2017","unstructured":"Kim J, Krueger JG. Highly Effective New Treatments for Psoriasis Target the IL-23\/Type 17 T Cell Autoimmune Axis. Annu Rev Med. 2017;68:255\u201369.","journal-title":"Annu Rev Med"},{"key":"973_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"key":"973_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397:754\u201366.","journal-title":"Lancet"},{"key":"973_CR5","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007;445:866\u201373.","journal-title":"Nature"},{"key":"973_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jaad.2013.12.036","volume":"71","author":"CW Lynde","year":"2014","unstructured":"Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S. Interleukin 17A: toward a new understanding of psoriasis pathogenesis. J Am Acad Dermatol. 2014;71:141\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"973_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.immuni.2018.05.012","volume":"49","author":"M Wang","year":"2018","unstructured":"Wang M, Zhang S, Zheng G, Huang J, Songyang Z, Zhao X, et al. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A. Immunity 2018;49:66\u201379.e5.","journal-title":"Immunity"},{"key":"973_CR8","doi-asserted-by":"crossref","unstructured":"Matsumoto R, Dainichi T, Tsuchiya S, Nomura T, Kitoh A, Hayden MS, et al. Epithelial TRAF6 drives IL-17-mediated psoriatic inflammation. JCI Insight. 2018;3:e121175.","DOI":"10.1172\/jci.insight.121175"},{"key":"973_CR9","doi-asserted-by":"publisher","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","volume":"111","author":"HL Ha","year":"2014","unstructured":"Ha HL, Wang H, Pisitkun P, Kim JC, Tassi I, Tang W, et al. IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci USA. 2014;111:E3422\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"973_CR10","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1091\/mbc.e04-10-0878","volume":"16","author":"G Crambert","year":"2005","unstructured":"Crambert G, Li C, Claeys D, Geering K. FXYD3 (Mat-8), a new regulator of Na,K-ATPase. Mol Biol Cell. 2005;16:2363\u201371.","journal-title":"Mol Biol Cell"},{"key":"973_CR11","doi-asserted-by":"publisher","first-page":"F241","DOI":"10.1152\/ajprenal.00126.2005","volume":"290","author":"K Geering","year":"2006","unstructured":"Geering K. FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Ren Physiol. 2006;290:F241\u201350.","journal-title":"Am J Physiol Ren Physiol"},{"key":"973_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10549-015-3667-x","volume":"155","author":"CC Liu","year":"2016","unstructured":"Liu CC, Teh R, Mozar CA, Baxter RC, Rasmussen HH. Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and gamma-radiation on Na(+)\/K(+)-ATPase and cell survival. Breast Cancer Res Treat. 2016;155:203\u201313.","journal-title":"Breast Cancer Res Treat"},{"key":"973_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ijc.21257","volume":"118","author":"H Kayed","year":"2006","unstructured":"Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, et al. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer. 2006;118:43\u201354.","journal-title":"Int J Cancer"},{"key":"973_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1158\/1541-7786.MCR-18-0610","volume":"17","author":"Y Xue","year":"2019","unstructured":"Xue Y, Lai L, Lian W, Tu X, Zhou J, Dong P, et al. SOX9\/FXYD3\/Src Axis Is Critical for ER(+) Breast Cancer Stem Cell Function. Mol Cancer Res. 2019;17:238\u201349.","journal-title":"Mol Cancer Res"},{"key":"973_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648\u201351.","journal-title":"Nature"},{"key":"973_CR16","doi-asserted-by":"crossref","unstructured":"Li F, Adase CA, Zhang LJ. Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin. J Vis Exp. 2017;125:56027.","DOI":"10.3791\/56027-v"},{"key":"973_CR17","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol. 2009;182:5836\u201345.","journal-title":"J Immunol"},{"key":"973_CR18","doi-asserted-by":"crossref","unstructured":"Broggi A, Cigni C, Zanoni I, Granucci F. Preparation of Single-cell Suspensions for Cytofluorimetric Analysis from Different Mouse Skin Regions. J Vis Exp. 2016;110:e52589.","DOI":"10.3791\/52589"},{"key":"973_CR19","doi-asserted-by":"crossref","unstructured":"Prinz I, Sandrock I, Mrowietz U. Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment. J Exp Med. 2020;217:e20191397.","DOI":"10.1084\/jem.20191397"},{"key":"973_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL. IL-17 Signaling: The Yin and the Yang. Trends Immunol. 2017;38:310\u201322.","journal-title":"Trends Immunol"},{"key":"973_CR21","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","volume":"20","author":"X Li","year":"2019","unstructured":"Li X, Bechara R, Zhao J, McGeachy MJ, Gaffen SL. IL-17 receptor-based signaling and implications for disease. Nat Immunol. 2019;20:1594\u2013602.","journal-title":"Nat Immunol"},{"key":"973_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ni.2081","volume":"12","author":"D Sun","year":"2011","unstructured":"Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol. 2011;12:853\u201360.","journal-title":"Nat Immunol"},{"key":"973_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ni.2080","volume":"12","author":"K Bulek","year":"2011","unstructured":"Bulek K, Liu C, Swaidani S, Wang L, Page RC, Gulen MF, et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol. 2011;12:844\u201352.","journal-title":"Nat Immunol"},{"key":"973_CR24","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20150204","volume":"212","author":"L Wu","year":"2015","unstructured":"Wu L, Chen X, Zhao J, Martin B, Zepp JA, Ko JS, et al. A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis. J Exp Med. 2015;212:1571\u201387.","journal-title":"J Exp Med"},{"key":"973_CR25","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1084\/jem.20100703","volume":"207","author":"S Zhu","year":"2010","unstructured":"Zhu S, Pan W, Shi P, Gao H, Zhao F, Song X, et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J Exp Med. 2010;207:2647\u201362.","journal-title":"J Exp Med"},{"key":"973_CR26","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.cellsig.2014.08.011","volume":"26","author":"L Cabal-Hierro","year":"2014","unstructured":"Cabal-Hierro L, Rodriguez M, Artime N, Iglesias J, Ugarte L, Prado MA, et al. TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2. Cell Signal. 2014;26:2658\u201366.","journal-title":"Cell Signal"},{"key":"973_CR27","doi-asserted-by":"publisher","first-page":"55855","DOI":"10.1074\/jbc.M407284200","volume":"279","author":"L He","year":"2004","unstructured":"He L, Grammer AC, Wu X, Lipsky PE. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. J Biol Chem. 2004;279:55855\u201365.","journal-title":"J Biol Chem"},{"key":"973_CR28","first-page":"3417","volume":"9","author":"BW Morrison","year":"1994","unstructured":"Morrison BW, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417\u201326.","journal-title":"Oncogene"},{"key":"973_CR29","doi-asserted-by":"crossref","unstructured":"Grzmil M, Voigt S, Thelen P, Hemmerlein B, Helmke K, Burfeind P. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol. 2004;24:97\u2013105.","DOI":"10.3892\/ijo.24.1.97"},{"key":"973_CR30","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585\u2013600.","journal-title":"Nat Rev Immunol"},{"key":"973_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.immuni.2018.03.019","volume":"48","author":"M Xu","year":"2018","unstructured":"Xu M, Lu H, Lee YH, Wu Y, Liu K, Shi Y, et al. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation. Immunity 2018;48:787\u201398.e4.","journal-title":"Immunity"},{"key":"973_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.biocel.2008.10.022","volume":"41","author":"G Tonel","year":"2009","unstructured":"Tonel G, Conrad C. Interplay between keratinocytes and immune cells-recent insights into psoriasis pathogenesis. Int J Biochem Cell Biol. 2009;41:963\u20138.","journal-title":"Int J Biochem Cell Biol"},{"key":"973_CR33","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos S, Mohebiany AN, Waisman A, Kurschus FC. Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes. J Invest Dermatol. 2019;139:1110\u20137.","journal-title":"J Invest Dermatol"},{"key":"973_CR34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jid.2018.01.036","volume":"138","author":"N Vandeghinste","year":"2018","unstructured":"Vandeghinste N, Klattig J, Jagerschmidt C, Lavazais S, Marsais F, Haas JD, et al. Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis. J Invest Dermatol. 2018;138:1555\u201363.","journal-title":"J Invest Dermatol"},{"key":"973_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/jdv.16126","volume":"34","author":"F Lauffer","year":"2020","unstructured":"Lauffer F, Jargosch M, Baghin V, Krause L, Kempf W, Absmaier-Kijak M, et al. IL-17C amplifies epithelial inflammation in human psoriasis and atopic eczema. J Eur Acad Dermatol Venereol. 2020;34:800\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"973_CR36","doi-asserted-by":"crossref","unstructured":"Garg AV, Ahmed M, Vallejo AN, Ma A, Gaffen SL. The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling. Sci Signaling. 2013;6:ra44.","DOI":"10.1126\/scisignal.2003699"},{"key":"973_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri2998","volume":"11","author":"H Hacker","year":"2011","unstructured":"Hacker H, Tseng PH, Karin M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 2011;11:457\u201368.","journal-title":"Nat Rev Immunol"},{"key":"973_CR38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet 2021;397:1301\u201315.","journal-title":"Lancet"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-00973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-00973-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-00973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T02:04:15Z","timestamp":1677549855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-023-00973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1038\/s41423-023-00973-7","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}